JPI InvestFranΓ§ais
JPI AI Analyst AI assistant Β· JPI Invest
Answers based on the tool's data Β· not financial advice Β· full analysis (free)
All stocks β€Ί Consumer Staples β€Ί KDP

Are analysts right about Keurig Dr Pepper (KDP)?

Consumer Staples Β· price $31.88 Β· median target $37.50 (+18%)
In short β€” Over the past 12 months, 13% of analyst price targets on Keurig Dr Pepper turned out profitable, for an average return of -2% (across 84 timestamped calls). The current consensus is "Buy" with a median price target of $37.50 (+18% vs the current $31.88, from 10 analysts).

πŸ“ˆ See the interactive version (live chart) β†’

πŸ”— Related pages on Keurig Dr Pepper β€” Financials & fundamentals  Β·  If I had invested  Β·  Dividend
Current price
$31.88
Median target (12 mo)
$37.50 +18%
Analyst accuracy (1 yr)
13%
Avg return / call (1 yr)
-2%
πŸ’° Performance & Β« if I invested Β» πŸ“Š Interactive analysis

Historical analyst accuracy

For Keurig Dr Pepper, we replayed every analyst price target of the past 12 months and measured the real outcome: 13% were profitable, average return -2% (84 calls). At 3 months: +0% average return (31% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) β€” not a forecast of what will happen.

Analyst / brokerCalls i% profitable iAvg return i
Barclays2313%-2%
JP Morgan90%-8%
Wells Fargo70%-11%
RBC Capital714%-3%
UBS60%-6%

Valuation

Is Keurig Dr Pepper overvalued, and is it a good time to buy Keurig Dr Pepper right now? If you're wondering, here's a recap to make up your own mind: Keurig Dr Pepper's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.

The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β€” but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.

MetricKeurig Dr PepperSector median (Consumer Staples)
P/E32.524.4
Forward P/E12.615.6
Net margin7%7%

πŸ‘‰ Keurig Dr Pepper trades above its sector median (32.5 vs 24.4) β€” the market expects higher growth; watch out for disappointment.

πŸ“– P/E, PEG, margin…: see the glossary

πŸ’΅ Dividend : Keurig Dr Pepper pays about $0.92/share/yr β†’ 2.76% yield. what is this?

Frequently asked questions

Is Keurig Dr Pepper a buy right now?

The analyst consensus on Keurig Dr Pepper (KDP) is "Buy" (23 bullish, 1 bearish calls over 12 months). This is not advice: historically, 13% of their targets on this stock turned out profitable over 1 year.

What is Keurig Dr Pepper's price target?

The median 12-month price target is $37.50 (+18% vs $31.88), ranging from $28.00 to $40.00 (10 analysts).

Are analysts accurate on Keurig Dr Pepper?

Over 1 year, 13% of analyst targets on Keurig Dr Pepper were profitable, for an average return of -2% (across 84 timestamped calls). This is JPI Invest's accuracy metric.

What is the Keurig Dr Pepper stock forecast?

Analysts target a median of $37.50 within 12 months, i.e. +18% vs the current price. The most bullish targets $40.00, the most cautious $28.00.

What is the Keurig Dr Pepper stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $37.50, +18%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (13%), and the stock's past trajectory.

Is Keurig Dr Pepper overvalued?

Its P/E is 32.5, forward P/E 12.6. A forward P/E lower than the current P/E means earnings are expected to grow.

πŸ“Š See the full interactive analysis of Keurig Dr Pepper β†’

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β€” on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free β†’ How it works: the method β†’

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.